搜索筛选:
搜索耗时2.7896秒,为你在为你在102,285,761篇论文里面共找到 7 篇相符的论文内容
发布年度:
Managing Australian Defence Force Activities in Marine Protected Areas:Using Jervis Bay as a Case St
[期刊论文] 作者：Lingdi Zhao,Xiaohua Wang,Brian,
来源：中国海洋经济评论 年份：2004
Australian Defence Force has done training activities in marine areas even some marine protected areas for a long time.These activities may cause pollution to t...
Managing Australian Defence Force Activities in Marine Protected Areas:Using Jervis Bay as a Case St
[期刊论文] 作者：Lingdi Zhao,Xiaohua Wang,Brian,
来源：中国海洋经济评论 年份：2008
Australian Defence Force has done training activities in marine areas even some marine protected areas for a long time.These activities may cause pollution to t...
A retrospective analysis of RetroNectin-activated cytokine-induced killer cells therapy in the treat
[会议论文] 作者：wei li,huiying zhang,lingdi zhao,ling mai,linping xu,quanli gao,yaomei wang,
来源：第八届中国肿瘤学术大会暨第十三届海峡两岸肿瘤学术会议 年份：2014
...
A retrospective analysis of RetroNectin-activated cytokine-induced killer cells therapy in the treat
[会议论文] 作者：wei li,huiying zhang,lingdi zhao,ling mai,linping xu,yaomei wang,quanli gao,
来源：第八届中国肿瘤学术大会暨第十三届海峡两岸肿瘤学术会议 年份：2014
...
A retrospective analysis of RetroNectin-activated cytokine-induced killer cells therapy in the treat
[会议论文] 作者：Wei Li,Huiying Zhang,Lingdi Zhao,Ling Mai,Linping Xu,Yaomei Wang,Quanli Gao,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
Objective: This retrospective study aims to explore the efficacy of RetroNectin-activated cytokine-induced killer cell (R-CIK) therapy in advanced hepatocellular carcinoma patients, which has not yet...
Predictive factors for inadequate stem cell mobilization in Chinese NHL and HL patients: 14-year exp
[会议论文] 作者：Xiaohong Han,Li Ma,Lingdi Zhao,Xiaohui He,Peng Liu,Shengyu Zhou,Jianliang Yang,Yan Qin,Sheng Yang,Jiarui,
来源：第五届中国肿瘤内科大会 年份：2011
Purpose: Factors affecting progenitor cell mobilization in patients with non-Hodgkins lymphoma (NHL) and Hodgkins lymphoma (HL) are incompletely understood.The aim of this retrospective study was to d...
[期刊论文] 作者：Lu Han,Jian Zhou,Linlin Li,Keshu Zhou,Lingdi Zhao,Xinghu Zhu,Qingsong Yin,Yufu Li,Hongqin You,Jishuai,
来源：癌症生物学与医学（英文版） 年份：2021
Objective: Chimeric antigen receptor-modified T (CAR-T) cells have shown impressive results against relapsed/refractory B cell malignancies. However, the traditional manufacture of CAR-T cells requires leukapheresis to isolate large amounts......
相关搜索：
